Form 4 for LFST LifeStance Health Group, Inc.
Accepted 2026-03-11 00:00:00 ET · period of report 2026-03-09 · accession 0001193125-26-102646 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-03-11 | 2026-03-09 | LFST | Varanakis Ann | CHRO | F - Tax | $6.91 | -45.0K | 371.7K | -11% | -$310.7K |
| M | 2026-03-11 | 2026-03-09 | LFST | Varanakis Ann | CHRO | A - Grant | $0.00 | +86.6K | 398.5K | +28% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-09 | F | D | 25,024 | $6.91 | 422,037 | D | — | — | |
| 2 | Common | Common Stock | 2026-03-09 | A | A | 59,789 | $0.00 | 447,061 | D | — | — | (F4) Represents PSUs previously granted to the Reporting Person on February 27, 2025, which vested on March 9, 2026. |
| 3 | Common | Common Stock | 2026-03-09 | F | D | 11,232 | $6.91 | 387,272 | D | — | — | |
| 4 | Common | Common Stock | 2026-03-09 | F | D | 8,707 | $6.91 | 371,668 | D | — | — | |
| 5 | Common | Common Stock | 2026-03-09 | A | A | 26,836 | $0.00 | 398,504 | D | — | — | (F2) Represents performance-based restricted stock units ("PSUs") previously granted to the Reporting Person on March 6, 2025, which vested on March 9, 2026. |